| Line Item | 2026-03-28 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $58.2M | — | -15.3% |
| Cost of Revenue | $56.2M | — | -19.4% |
| Gross Profit | $2.0M | — | +286.4% |
| R&D Expense | $5.2M | — | -30.0% |
| SG&A Expense | $37.9M | — | -20.6% |
| Operating Income | -$41.1M | — | +26.9% |
| Pre-tax Income | -$28.5M | — | +46.2% |
| Income Tax | $0 | — | — |
| Net Income | -$28.5M | — | +46.2% |
| EPS (Basic) | -$0.06 | — | +91.3% |
| EPS (Diluted) | -$0.06 | — | +91.3% |
| Line Item | 2026-03-28 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $191.0M | -6.3% | +87.0% |
| Accounts Receivable | $25.9M | -0.5% | -22.1% |
| Inventory | $68.9M | -18.0% | -31.2% |
| Current Assets | $311.0M | -8.9% | +20.9% |
| Total Assets | $579.5M | -5.7% | -10.0% |
| Current Liabilities | $109.0M |
| Line Item | 2026-03-28 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$5.0M | — | +80.8% |
| Capital Expenditures | $2.5M | — | -43.7% |
| Investing Cash Flow | -$1.8M | — | +56.9% |
| Financing Cash Flow | -$4.5M | — | -663.5% |
| Free Cash Flow | -$7.6M | — | +75.3% |
| +43.6% |
| Long-term Debt | $411.6M | -1.0% | -64.0% |
| Stockholders' Equity | -$21.1M | -2014.6% | +96.8% |